| abstract |
The invention provides a colorectal cancer prediction system and its application. By using the method of metabolomics, by analyzing the metabolites with significant differences in the urine of colorectal cancer patients and normal people, screening out a series of metabolites that can predict colorectal cancer early Biomarkers of the risk of rectal cancer, and further screen out a group of biomarkers to build a diagnostic model of colorectal cancer, which can be used to predict whether an individual has colorectal cancer conveniently, non-invasively and efficiently, meeting clinical needs. |